Speech: What space will excipients occupy in our consciousness in the next decade? + Panel: What is needed to drive excipient innovation for first class drug products for the future?

Description

Watch Ajaz Hussain’s presentation from the ExciPerience 2021 here!

Speech: In our progress towards the science of pharmaceutical quality, the immaturity of the science of materials we call excipients or inactive ingredients determines our regulatory and quality management systems’ maturity. Effective corrective and preventive action to stop repeating mistakes is but a step to credibility.

Sustainability of the sector demands continual improvement in control of excipients and innovating new excipients that assure reliability at wrap speed in real-time.  The maturity of a system is not just the maturity of some of its parts. Increasing the order of excipient consciousness is essential to compliance in the age of lockdowns & disruptions.

Panel: This panel discussion focusses on the need for novel excipients going forward to help us innovate in drug development and solve patient issues. Novel excipients are going to be very important going forward to resolve many of the issues we all have with drug solubility, patient-centric dosage form development for improved compliance, the implementation of advanced technologies in manufacturing such as continuous manufacturing and 3D Printing and many other drug development challenges.

In touching these questions this panel tries to summarize the various topics and ideas raised during the two ExciPerience days and gives an outlook on the future of excipients.

---

The Exciperience covered all areas from basic or advanced research and formulation to manufacturing and regulatory. It was the intersection between all the different perspectives and people in the excipient community.